COVID-19 Vaccines
Latest COVID-19 vaccine updates
- The 2025/2026 COVID-19 vaccine program has transitioned to an annual program, with guidance issued each year for the September to August respiratory season.
- Everyone six months of age and older who lives, works, or goes to school in Ontario is eligible for COVID-19 vaccine.
- There are two COVID-19 vaccines available, Moderna Spikevax and Pfizer BioNTech Comirnaty. Both are considered to be equivalent and provide the same protection against COVID-19 disease. Individuals who are unable to receive an mRNA vaccine should speak with their health care provider about how to lower their risk of SARS-CoV-2 infection, and about treatment options, including Paxlovid.
- COVID-19 vaccines may be given at the same time with other vaccines, or at any time before or after other vaccines, including influenza and respiratory syncytial virus (RSV) .
Vaccine eligibility and doses
The Ontario Ministry of Health is recommending an annual dose of COVID-19 vaccine with eligibility and timing of immunization divided into four groups: high-risk group 1, high-risk group 2, priority populations, and general population.
The following groups should receive one annual dose of COVID-19 vaccine, unless they have not completed their primary series:
- High-risk populations group 2
- Priority populations
- General population
Individuals belonging to high-risk population group 1 should receive two doses per year (one fall dose and one spring dose), unless they have not completed their primary series.
High-risk populations group 1 |
The following individuals are at increased risk of COVID-19 disease and should receive COVID-19 vaccine dose(s) as soon as it becomes available in the fall and should receive an additional dose in the spring:
Adults aged 65 to 79 years should receive COVID-19 vaccine dose(s) as soon as it becomes available in the fall and may receive an additional dose in the spring. Certain individuals in this age group are at increased risk of severe COVID-19 disease and would benefit from doses in the fall and spring. *Individuals with immunocompromising conditions, including those receiving immunosuppressive therapy, are at increased risk for prolonged infection, serious complications from SARS-CoV-2 infection as well as reduced immune responses to vaccination. Additional doses may help improve the immune response and vaccine effectiveness. The following individuals are considered to be moderately to severely immunocompromised and are recommended to receive an additional dose this spring:
|
High-risk populations group 2 |
The following individuals are at increased risk of SARS-CoV-2 exposure or severe COVID-19 disease and should receive COVID-19 vaccine dose(s) as soon as it becomes available in the fall:
|
Priority populations |
The following individuals, may receive COVID-19 vaccine dose(s) as soon as it becomes available in the fall:
|
General population |
All individuals (six months of age and older) who do not belong to the high-risk or priority populations described above may receive COVID-19 vaccine dose(s) in the fall, starting on October 27, 2025. |
After determining your risk category, review your COVID-19 vaccine history.
Not previously vaccinated |
A primary series should be initiated or completed during fall 2025. A primary series of one (1) dose of COVID-19 vaccine is recommended for those aged five years and older who have not received any COVID-19 vaccines prior to the 2025-2026 season and are not immunocompromised. For those aged five and older who have not been previously vaccinated and are moderately to severely immunocompromised, two (2) doses are recommended for a primary series, and a third dose may also be offered. A primary series of two (2) doses of COVID-19 vaccine is recommended for children aged six months to four years who have not received any COVID-19 vaccines prior to the 2025-2026 season and are not immunocompromised. For those aged six months to four years who have not been previously vaccinated and are moderately to severely immunocompromised, three (3) doses are recommended for a primary series. |
Previously vaccinated |
High-risk populations groups 1 and 2 should, and priority populations may receive doses as soon as they are available. The general population may receive doses starting on October 27, 2025. For more information about vaccine schedules and intervals for previously vaccinated individuals, see Ontario Ministry of Health updates. |
Re-vaccination |
Speak to your health care provider if you have received a hematopoietic stem cell transplant (autologous or allogeneic) or have had (CAR)-T-cell therapy after previous COVID-19 vaccination(s). |
Where to get vaccinated
Eligible individuals six months and older can receive the COVID-19 vaccine at participating pharmacies and select health care providers. Most pharmacies book appointments ahead of time and some allow walk-ins. Check with your pharmacy or health care provider before you go.
Find a participating pharmacy near you
Durham Region Health Department will be offering COVID-19 vaccines for children six-months to four-years of age who are unable to access COVID-19 vaccines through a pharmacy or health care provider. Book an appointment.
Homebound immunization for eligible clients |
If you or someone you know meets the above criteria, you may be eligible for COVID-19 vaccine homebound immunization. Some pharmacies offer homebound vaccination services, check with your local participating pharmacy. |
Proof of vaccination and receipts
- Proof of COVID-19 vaccination is no longer required for businesses.
- Businesses can voluntarily implement a proof of COVID-19 vaccination requirement upon entry to their facility.
COVID-19 vaccine receipts | ||
|
||
Reporting vaccines received outside of Ontario or Canada | ||
Out of province entries requires a careful manual review, verification and data input by staff. Submissions with incomplete or unclear information, including errors may take additional time to process as they require additional follow-up with client or the organization where the vaccines were administered. If you live in Durham Region and received COVID vaccine doses outside of Ontario, please use our online form to report your vaccine(s). Please only complete this form if:
You can document individual COVID-19 vaccines or a full series. You will be required to submit proof of vaccination. Examples of proof include:
Some individuals vaccinated in Ontario received vaccine from what is referred to as non-Ontario stock. This refers to vaccine that was not allocated to Ontario or recorded in the provincial vaccine management system. Generally, these doses were delivered at institutions such as correctional facilities, military groups or embassies. Individuals who received doses of vaccine from the non-Ontario stock may also report out non-Ontario stock vaccinations to Durham Region Health Department using our online form. |
||
Requesting a name change on QR codes | ||
Name changes on your vaccine certificate |
Frequently asked questions about COVID-19 vaccines
Children six-months to under five-years old | ||||||||||||
|
||||||||||||
Children five to 11-years old | ||||||||||||
|
||||||||||||
General COVID-19 vaccine information | ||||||||||||
|
Medical and safety information | ||||||||||
|
Vaccine approval and clinical trial (testing) information |
How was Health Canada able to approve the COVID-19 vaccine so quickly? Creating a new vaccine can take years. The COVID-19 vaccine happened so quickly for many reasons including:
Health Canada developed a fast-track review process to assess COVID-19 vaccines. Vaccine manufacturers were able to submit research and new evidence for review by Health Canada as it becomes available and throughout clinic trials. Previously, all clinical trials had to be completed prior to applying for Health Canada approval. Health Canada has implemented greater scientific resources, so reviews are completed in a timely manner without compromising any standards for vaccine use in Canada.
Check out this video for more information about how the COVID-19 vaccine was developed. To learn more about COVID-19 vaccine and the approval process, visit Health Canada's website. |
Where can I get more information? |
|
Resources in other languages
COVID-19 communication resources | ontario.ca
Resources for Indigenous Peoples
The facts about COVID-19 vaccines
EnglishCree Inuktitut Objibwe Eastern
Contact Us